Cytarabine, daunorubicin and etoposide (ADE) chemotherapy in acute myeloid leukemia (AML) patients >= 60 years (CALGB 9720)
- Citation:
- Blood vol 110 (11) 94A-94A
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 87
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. R. Baer S. L. George B. L. Sanford S. M. Bothun K. Mrozek K. L. O'Loughlin J. E. Kolitz J. O. Moore R. M. Stone B. L. Powell M. A. Caligiuri C. D. Bloomfield R. A. Larson
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8461, CALGB-9720
- Phases:
- 3, N/A
- Keywords: